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Abstract
The global-scale epidemiology and genome-wide evolutionary dynamics of influenza B
remain poorly understood compared with influenza A viruses. We compiled a spatio-tempo-
rally comprehensive dataset of influenza B viruses, comprising over 2,500 genomes sam-
pled worldwide between 1987 and 2015, including 382 newly-sequenced genomes that fill
substantial gaps in previous molecular surveillance studies. Our contributed data increase
the number of available influenza B virus genomes in Europe, Africa and Central Asia,
improving the global context to study influenza B viruses. We reveal Yamagata-lineage
diversity results from co-circulation of two antigenically-distinct groups that also segregate
genetically across the entire genome, without evidence of intra-lineage reassortment. In
contrast, Victoria-lineage diversity stems from geographic segregation of different genetic
clades, with variability in the degree of geographic spread among clades. Differences
between the lineages are reflected in their antigenic dynamics, as Yamagata-lineage
viruses show alternating dominance between antigenic groups, while Victoria-lineage
viruses show antigenic drift of a single lineage. Structural mapping of amino acid substitu-
tions on trunk branches of influenza B gene phylogenies further supports these antigenic dif-
ferences and highlights two potential mechanisms of adaptation for polymerase activity. Our
study provides new insights into the epidemiological and molecular processes shaping influ-
enza B virus evolution globally.
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Author summary
Influenza B viruses cause roughly one third of the global influenza disease burden. How-
ever, many important questions regarding the global-scale molecular epidemiology and
evolutionary dynamics of influenza B virus have yet to be comprehensively addressed
compared to influenza A virus. This is in part due to limited globally-sampled genomic
data. We improved the availability of influenza B virus data by sequencing over 350 full
genomes, fillings gaps from under-sampled regions by as much as 12-fold. Using a dataset
of over 2,500 influenza B virus genomes, we show major differences in the genome-wide
evolution, molecular adaptation, and geographic spread between the two major influenza
B lineages. These findings have implications for vaccine design and improve our under-
standing of influenza virus evolution.
Introduction
Influenza viruses cause significant morbidity and mortality worldwide and present major
challenges for public health. Two types of influenza virus circulate widely in human popula-
tions: influenza A and influenza B viruses. While rates of hospitalization and mortality attrib-
uted to influenza B are lower than for influenza A subtype A(H3N2), they were higher than
the less virulent seasonal A(H1N1) subtype of influenza A viruses [1]. Influenza B viruses
cause epidemics worldwide each year, contributing approximately one third of the global
influenza disease burden [2], and are associated particularly with severe disease in children
[1,3]. Despite the significance of influenza B viruses to public health, their epidemiological
characteristics and their global evolutionary and antigenic dynamics are poorly understood
compared to influenza A viruses [4,5]. Influenza B viruses are classified into two co-circulat-
ing phylogenetically- and antigenically-distinct lineages, named after viruses B/Yamagata/
16/88 (Yamagata-lineage) and B/Victoria/2/87 (Victoria-lineage) that diverged in the 1970s
[6,7]. The Yamagata- and Victoria-lineages have had a complex epidemiological history
since their divergence, co-circulating globally since at least 2002 and often alternating in
regional dominance [8]. Disparities from antigenic mismatches between the predominant
circulating influenza B virus lineage in a given year and that year’s seasonal influenza triva-
lent vaccine (which contains representatives of A(H1N1), A(H3N2) plus one of the two
influenza B virus lineages) have occurred. Consequently, updated quadrivalent vaccines that
contain representative Yamagata-lineage and Victoria-lineage viruses have been recom-
mended [9].
A number of studies have reported the genetic and epidemiological characteristics of influ-
enza B viruses in specific geographic regions [2,10–15] yet few have investigated the large-scale
evolutionary dynamics of influenza B viruses at the genome-wide level or global scale [16–19].
Nevertheless, existing insights into the evolutionary dynamics of influenza B viruses show they
undergo slower antigenic evolution than influenza A viruses [19,20], with genetic changes
including nucleotide insertions, nucleotide deletions, and frequent reassortment events
between and within lineages, contributing to their continued diversification [16,17,21,22].
Recent analyses have revealed that the polymerase basic 1 and 2 (PB1, PB2) and hemagglutinin
(HA) genes of Victoria- and Yamagata-lineage viruses remain as distinct lineages despite high
levels of overall reassortment, likely through genomic incompatibility among viral genome
segments [17,23]. Other differences between the two lineages have been observed; Victoria-
lineage viruses appear to undergo more rapid lineage turnover and antigenic drift [18] and
persist for longer in local geographic regions before wider dissemination [19]. Despite these
Genome-wide evolution of influenza B viruses on a global scale
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006749 December 28, 2017 2 / 26
Funding: PL, SE, AG, PK, and SJW were supported
by the Wellcome Trust (098051; wellcome.ac.uk).
GD was supported by a Natural Environment
Research Council studentship (D76739X; www.
nerc.ac.uk) and the Mahan Postdoctoral Fellowship
from the Fred Hutchinson Cancer Research Centre
(www.fredhutch.org). TAB is supported by the
Medical Research Council (MR/L009528/1; www.
mrc.ac.uk) and Wellcome Trust (090532/Z/09/Z).
TB is a Pew Biomedical Scholar (www.pewtrusts.
org) and his work is supported by NIH award (R35
GM119774-01; www.nih.gov). CAR was supported
by a University Research Fellowship from the Royal
Society (royalsociety.org). OGP is supported by the
European Research Council (ERC) under the
European Union’s Seventh Framework Programme
(FP7/2007-2013/ERC grant 614725-
PATHPHYLODYN; erc.europa.eu). The work at the
Worldwide Influenza Centre (RSD, JM) was
supported by the Francis Crick Institute, which
receives its core funding from Cancer Research UK
(FC001030; www.cancerresearchuk.org), the UK
Medical Research Council (FC001030) and the
Wellcome Trust (FC001030). The funders had no
role in study design, data collection and analysis,
decision to publish, or preparation of the
manuscript.
Competing interests: The authors have declared
that no competing interests exist.
advances, there remain substantial unanswered questions about the genomic evolution of
influenza B viruses on a global scale, including whether the genetic differentiation observed
in HA is mirrored in other less-studied gene segments and the influence of geography on
genome-wide viral genetic diversity. Until recently, efforts to address these issues have been
hampered by the paucity of globally sampled influenza B virus hemagglutination inhibition
(HI) data and full-length genome sequences available, particularly from Europe, Africa, Cen-
tral Asia, and South America.
To address this, we used samples from multiple locations worldwide to generate 382 new
complete influenza B virus genome sequences. We further compiled the largest and most spa-
tio-temporally-representative dataset of influenza B virus whole genome sequences to date.
This dataset included 2,651 complete genomes (1,265 Yamagata- and 1,386 Victoria-lineage
HA viruses) sampled worldwide between 1987 and 2015. We used antigenic cartography and
phylogenetic approaches to identify patterns of reassortment, compare the dynamics of anti-
genic evolution among lineages, and characterize genome-wide demographic histories in geo-
graphic regions. We identify substitutions along the trunk branches of the phylogenies for
each gene and structurally map changes in the HA and polymerase complex that may contrib-
ute to molecular adaptation. Our study shows how the global phylodynamics and epidemio-
logic interactions of influenza B viruses are shaped by reassortment, genomic compatibility,
and differing patterns of antigenic change.
Results
New influenza B virus genome sequences from multiple locations
worldwide
For this study, we sequenced and assembled 382 new, full-length genomes of influenza B
viruses collected globally from 2007 to 2013 (Fig 1). In total, we analyzed all available gene
sequence data from over 10,000 distinct influenza B viruses sampled from 1987 to 2015, of
which 2,651 were complete genomes. Our sequencing efforts increased the total number of
complete influenza B genomes by 17%, with the new genomes representing a 44% increase in
the number of genomes for the years 2008–2013 (Fig 1B). Crucially, our genomes were sam-
pled from geographic regions under-represented by previous influenza B virus molecular sur-
veillance. Specifically, we increased the number of genomes from Europe (20 to 243 genomes),
Africa (11 to 89 genomes), Central Asia (10 to 37 genomes), and South America (21 to 31
genomes). Our sequencing has therefore substantially improved the global context of influenza
B genomic diversity (Fig 1A). One region that remains deficient in influenza B genome
sequences is the Indian subcontinent, as assessed by lack of submission to sequence databases,
which was previously shown to be an important source of influenza A and B virus diversity
[19]. Despite this, our study encompasses the most comprehensive dataset of influenza B com-
plete genomes to date.
Divergence and reassortment in Yamagata- and Victoria-lineage viruses
The Yamagata-lineage has been separated previously into two major antigenically distinct
clades (clade 2, the B/Massachusetts/02/2012 clade, and clade 3, the B/Wisconsin/1/2010
clade), based on phylogenetic analysis of its HA and neuraminidase (NA) genes [24,25].
However, it was unknown whether this separation also extended to the other genes. Our
analysis demonstrates that this phylogenetic divergence is indeed present across all genes,
resulting in each Yamagata-lineage clade comprising a distinct ‘whole genome’ genotype
(Fig 2, S1 Fig). Using molecular clock phylogenetic analysis, we estimated that this whole
Genome-wide evolution of influenza B viruses on a global scale
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genome split occurred progressively over a period of approximately 10 years, beginning with
the PB1 segment around 1993 (95% highest posterior density (HPD) 1992–1994) (S2 Fig),
followed by polymerase acidic protein (PA) in 1996 (95% HPD 1995–1997), then nucleopro-
tein (NP), PB2, HA, NA, non-structural protein 1 (NS1), and matrix protein 1 (M1) in 2002–
2003 (95% HPD 2001–2004) (Table 1). While several Yamagata-Victoria inter-lineage reas-
sortment events were apparent after the genome-wide split of Yamagata-lineage viruses into
clades 2 and 3, especially for NA, we observe that after the split of Yamagata-lineage viruses,
there is little evidence of substantial reassortment between the Yamagata-lineage clades, with
them maintaining their unique genomic constellations for over 12 years (Fig 2, S2 Fig). In
contrast, Victoria-lineage influenza B viruses show evidence of continued reassortment
between clades within the Victoria-lineage over time. As a result, we observed multiple co-
circulating Victoria clades that do not maintain distinct genome constellations (Fig 3, S1 and
S3 Figs). In particular, we noted considerable inter-clade reassortment between recently cir-
culating B/Brisbane/60/2008 (clade 1A), B/Odessa/3886/2010 (clade 1B), and B/Malaysia/
2506/2004 clade viruses.
Fig 1. Source and distribution of available influenza B virus full genomes. (A) Geographic source and (B) temporal distribution of 2,651 unique
complete genomes analyzed in this study. Circle areas are proportional to the number of unique viruses originating from a location; smallest circle size
represents 1 genome, largest circle size represents 332 genomes. Pie chart fractions reflect proportion of unique full genomes that were either newly
generated in this study or downloaded from IVR and GISAID (on 25 August 2015). Viruses are classified as Victoria- or Yamagata-lineage by HA gene.
https://doi.org/10.1371/journal.ppat.1006749.g001
Genome-wide evolution of influenza B viruses on a global scale
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Fig 2. Maximum clade credibility tree inferred from 1,169 Yamagata-lineage HA gene sequences and corresponding genotype
constellations. Branches of the phylogeny are labeled with amino acid substitutions occurring along the phylogenetic ‘trunk’ and
colored by well-supported clade distinction (see legend). Clade classifications of each gene are similarly indicated by colored bars.
White bars indicate that no sequence was available for that gene. Nodes with greater than 0.70 posterior probability support are
shown with circle node shapes.
https://doi.org/10.1371/journal.ppat.1006749.g002
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Dynamics of antigenic evolution differ between Victoria- and Yamagata-
lineage viruses
The abovementioned differences in the genome-wide evolutionary patterns between Yama-
gata- and Victoria-lineage viruses led us to investigate if the genetic differences also extended
to the antigenic properties of the viruses, as measured by hemagglutination inhibition (HI)
data. We compiled available HI measurements and associated HA gene sequences for influ-
enza B viruses sampled between 1987–2013. We then removed known egg-adapted viruses,
resulting in a dataset of 309 Victoria- and 308 Yamagata-lineage viruses with both genetic and
antigenic data. We integrated these data under a Bayesian framework [20] to jointly infer the
antigenic and genetic relationships of influenza B viruses in two antigenic dimensions (Fig 4,
S4 Fig). Under a Bayesian multidimensional scaling (BMDS) model that does not account for
variations in virus avidities and serum potencies in the HI assays (‘fixed effects,’ model 7 in
[20]), the two extant Yamagata-lineage clades appear to experience little antigenic change
over time (S4 and S5 Figs) with an estimated drift rate slower than the Victoria-lineage, in line
with previous observations by Vijaykrishna et al. [18]. However, using a more comprehensive
model that does consider these experimental variations (‘full model,’ model 10 in [20]), we
found no significant difference in antigenic drift rate between the Victoria-lineage and the
Yamagata-lineage (Table 2), in agreement with Bedford et al. [20]. Previous model perfor-
mance testing indicated that the latter model provided the greatest predictive power and least
test error for HI titers [20], providing further support for influenza B virus lineages experienc-
ing antigenic drift at similar rates.
Despite comparable rates of antigenic drift, we observed notable differences in the
dynamics of antigenic evolution between the Victoria- and Yamagata- lineages. Around
2005, the genetically-distinct clades 1A and 1B of the Victoria-lineage emerged, replacing the
previously-circulating lineages and subsequently dominating the Victoria-lineage virus pop-
ulation (Fig 3). While the HA genes of these Victoria-lineage clades are clearly different (Fig
3), antigenic mapping showed they are not antigenically distinct (Fig 4A). Conversely, the
genetically-divergent Yamagata-lineage clade 2 and 3 viruses do exhibit measurable anti-
genic divergence (Fig 4B). In contrast to the serial replacement of novel antigenic types in
the Victoria-lineage viruses (Fig 4A), the two antigenically-distinct clades of the Yamagata-
lineage co-circulate globally, alternating in dominance (nextflu.org/yam/12y/) (S6 Fig).
However, despite the divergence and counter-cyclical maintenance of Yamagata-lineage
clades 2 and 3 over 10 years, recent reports indicate that the incidence of clade 2 viruses has
decreased substantially (https://www.crick.ac.uk/research/worldwide-influenza-centre/
annual-and-interim-reports/).
Table 1. Estimated time of most recent common ancestor (TMRCA) for Yamagata-lineage clade 2 and clade 3
viruses.
Gene Mean TMRCA 95% HPD lower 95% HPD upper
PB1 1993.690 1992.859 1994.292
PA 1996.780 1995.979 1997.474
NP 2002.545 2001.975 2002.995
PB2 2003.070 2002.727 2003.537
NA 2003.100 2002.443 2003.743
HA 2003.240 2002.831 2003.789
NS1 2003.500 2002.942 2003.974
M1 2003.550 2002.628 2004.980
https://doi.org/10.1371/journal.ppat.1006749.t001
Genome-wide evolution of influenza B viruses on a global scale
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Fig 3. Maximum clade credibility tree inferred from 1,019 Victoria-lineage HA gene sequences and corresponding genotype
constellations. See legend to Fig 2 for details.
https://doi.org/10.1371/journal.ppat.1006749.g003
Genome-wide evolution of influenza B viruses on a global scale
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Other long-lived Yamagata-lineage clades previously became extinct. In particular, B/
Yamanashi/166/98 clade viruses emerged in 1993 (95% HPD: 1992–1994), and constituted
the predominant circulating Yamagata-lineage clade worldwide until 2002, when they were
replaced by B/Harbin/7/94-like Yamagata-lineage viruses (Fig 2). Although these two Yama-
gata-lineage clades were genetically distinct, the B/Harbin/7/94 clade was antigenically similar
to the B/Yamanashi/166/98 clade (Fig 4B). Our whole-genome phylogenetic analysis showed
that in 2000–2001 (95% HPD: April 2000-April 2001) the B/Yamanashi/166/98 clade provided
the NA gene that became incorporated into the Victoria-lineage (S3 Fig). Subsequently, the
global incidence of Victoria-lineage viruses increased dramatically, while the B/Yamanashi/
166/98 clade went extinct. This suggests that factors involving other gene segments or differing
patterns of reassortment may have influenced influenza B lineage dynamics on a global scale.
However, we were unable to investigate this further due to limited availability of genome
sequences covering this time period.
Structural mapping of phylogenetic ‘trunk’ nonsynonymous substitutions
Given the observed influenza B virus inter-lineage differences in the phylodynamics and
patterns of antigenic evolution, we sought to compare levels of natural selection acting on Vic-
toria- and Yamagata-lineage viruses. As selective sweeps are difficult to detect by dN/dS meth-
ods, we used ancestral sequence reconstruction to quantify the accumulation of potentially
adaptive substitutions in all the major influenza B virus genes (Fig 5, S1 Fig, S1 Table). We
focused on amino acid changes occurring on the ‘trunk’ of the phylogenies, which are less
sensitive to varying sampling densities over time that occur due to differences in sequence
Fig 4. Antigenic and genetic evolutionary relationships of influenza B viruses. Antigenic maps of (A) 309 Victoria- and (B) 308 Yamagata-
lineage viruses shown in 2 antigenic dimensions over time (1987–2013), inferred by BMDS using HI titer data and HA sequences. Each circle
indicates a virus antigenic map location and lines represent phylogenetic relationships inferred between viruses.
https://doi.org/10.1371/journal.ppat.1006749.g004
Table 2. Estimated antigenic drift rate for influenza B virus Victoria and Yamagata lineages inferred using BMDS.
Full model Fixed effects model
Victoria Yamagata Victoria Yamagata
Antigenic drift rate (AU/year) 0.37 0.34 0.32 0.12
95% HPD (AU/year) 0.25–0.47 0.22–0.45 0.23–0.39 0.03–0.21
https://doi.org/10.1371/journal.ppat.1006749.t002
Genome-wide evolution of influenza B viruses on a global scale
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Fig 5. Estimated emergence of nonsynonymous substitutions along the major trunk lineage of the gene phylogenies of Victoria- and Yamagata-
lineage virus. Substitutions are summarized from S1 Fig for (A) Victoria-lineage, (B) Yamagata-lineage, (C) Yamagata-lineage clade 2 (B/Massachusetts/02/
2012 clade), and (D) Yamagata-lineage clade 3 (B/Wisconsin/1/2010 clade), with only substitutions emerging after 1995 shown for clarity. Circles represent
median and lines represent 95% HPD estimates of time of emergence across 1,000 posterior trees.
https://doi.org/10.1371/journal.ppat.1006749.g005
Genome-wide evolution of influenza B viruses on a global scale
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availability. Substitutions along the trunk represent changes that have fixed in the virus popu-
lation and are at least neutral or could confer selective advantages that are swept to fixation.
We first compared trunk substitutions in Victoria- and Yamagata- lineage HA phylogenies (S7
Fig). Fewer nonsynonymous changes were found along the trunk of the Victoria-lineage HA
phylogeny (mean: 0.81; 95% HPD: 0.76–0.86 nonsynonymous substitutions/year) than the
Yamagata-lineage phylogeny (mean: 1.06; 95% HPD: 0.93–1.17 nonsynonymous substitu-
tions/year) (Figs 2 and 3). Structural mapping of these trunk mutations showed that, in both
lineages, the majority of changes were in solvent-accessible residues on the globular head
region of HA (S7 and S8 Figs). As expected, these substitutions predominantly occurred within
predicted antigenic epitopes in the Yamagata- and Victoria-lineages [26, 27] (S7 and S8 Figs).
Since 2002 and the global re-emergence of the Victoria-lineage [16], both lineages have
experienced trunk substitutions in three residues located in HA1 antigenic epitopes; Yama-
gata-lineage (amino acid changes N116K, S150I, N202S) and Victoria-lineage (amino acid
changes K129N, I146V, N165K) (Figs 2 and 3, S7 Fig). Previous experimental work has shown
that transitions between influenza antigenic clusters are predominantly associated with substi-
tutions at sites near the receptor-binding site (RBS) [28]. We identified four trunk substitu-
tions adjacent to the RBS: V137I, which fixed early in Victoria-lineage HA prior to 1995 (Fig
3); residues N150S (and S150N), R162K, and N202S in Yamagata-lineage HA. We identified a
smaller number of trunk substitutions in structurally ‘buried’ residues, namely P108S, V179I
and V25M1 in Yamagata-lineage HA, with P108A notably a clade 2-defining substitution that
fixed early in the Yamagata-lineage clade 2/3 divergence (Fig 2).
Ancestral sequence reconstruction along the Victoria- and Yamagata-lineage HA phyloge-
nies also revealed residues that experienced multiple amino acid replacement and therefore
temporary fixation over time (Figs 2 and 3; S2 Table). For Victoria-lineage viruses, two such
positions (T75N/N75K, T129K/K129N) were solvent-accessible (exposed) residues of known
antigenic epitopes. For Yamagata-lineage viruses, residue N150S/S150I was in a partially-
exposed position within a major antigenic epitope, adjacent to the RBS. Additionally, we
observed a number of residues that experienced amino acid substitutions that subsequently
reverted back to their ancestral state. Three of these HA reversions (K48R/R48K in Yamagata-
lineage, V146I/I146V and T121I/I121T in Victoria-lineage) occurred in known antigenic epi-
topes, while two other reversion residues (172 in Victoria- and 179 in Yamagata-lineages)
were not located in or near predicted epitopes (S2 Table). Furthermore, we observed identical
substitutions in major antigenic epitopes (N116K, R149K) that emerged and became indepen-
dently fixed in different Yamagata-lineage clades. Both substitutions occurred in the B/Yama-
nashi/166/98 clade that went extinct around 2002, and around a similar time, R149K also
arose in B/Harbin/7/94 viruses. More recently, N116K became fixed in clade 3 viruses. Finally
we observed changes to a given residue that were different depending on the Yamagata-lineage
clade. In particular, around the year 2005, changes at residue 229 were independently fixed in
Yamagata-lineage clade 3 (as G229D) and clade 1 (B/Florida/4/2006 clade: G229S); clade 2
Yamagata-lineage viruses however, retained the ancestral amino acid (229G) at this site. Con-
sequently, from 2005–2010, the Yamagata-lineage comprised three co-circulating populations
that varied at position 229 in HA.
Applying the same rationale, we estimated the time of emergence of trunk substitutions
across the entire genome of Victoria- and Yamagata-lineage viruses (Fig 5). Over the 20-year
period, only one amino acid change, R105K present in contemporary Yamagata-lineage
viruses of both clades, fixed in matrix protein (M1) in the global influenza B virus population
(Fig 5B, S1B Fig). There was potential co-emergence of substitutions in some gene segments,
for example emergence of trunk substitutions in NS1 appeared to coincide with the emer-
gence of substitutions in NA. There was also evidence of temporal ordering of Yamagata-
Genome-wide evolution of influenza B viruses on a global scale
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lineage ‘clade-defining’ mutations, which first accumulated in PB1, followed by PA, and then
the rest of the genes (Fig 5C and 5D). To determine whether these early trunk substitutions
had potential functional consequences contributing to the clade 2/3 divergence of the Yama-
gata-lineage, we mapped them onto an influenza B virus polymerase complex structure (Fig
6). Yamagata-lineage clade 2 and clade 3 viruses accumulated changes in sites where PB1
and PA interact or where polymerase contacts viral RNA (vRNA), respectively. PB1-I357V
and PA-I617V substitutions fixed in clade 2 viruses; both residues are positioned at the
PB1-PA interface, with PA-617 at a known interaction site with the N-terminus of PB1 criti-
cal for PB1-PA binding [29] (Fig 6A and 6B). Differently, PB1-K652R and PB1-H38Y substi-
tutions fixed in clade 3 viruses, both potentially interact with vRNA bound in the polymerase
structure [30] (Fig 6C and 6D). Additional substitutions occurred in sites of the polymerase
structure not at these interfaces. Around the same time (1996, 95% HPD 1996–1997 (S1
Table)), K390R and K391R PB1 substitutions emerged in Yamagata-lineage clade 2 and
clade 3 viruses, respectively, which are located beside each other and are exposed on the poly-
merase structure (S9 Fig). Further, three ‘clade-defining’ substitutions that emerged later
appeared to be ‘buried’ in the polymerase subunits: PB2-L555M in clade 2 viruses, and
PA-V485I and PB1-V66I in clade 3 viruses (S9 Fig).
Spatial population structure observed in Victoria- but not Yamagata-
lineage viruses
Finally, we sought to determine whether the differences in the molecular evolutionary dynam-
ics of Victoria- and Yamagata-lineage viruses that we observed at the global level were also
present at regional scales. Previous studies have focused either on the circulation of influenza
B viruses in a specific geographic region [18,31], or have analyzed the global circulation of the
HA segment only. Unlike influenza A(H3N2) HA, influenza B HA lineages circulate indepen-
dently in China, India, and Southeast Asia for long periods of time before spreading elsewhere
in the world [19]. Here new data, especially from Europe, enables us to combine these two
approaches and analyze whole virus genomes within specific geographic regions: Europe, the
United States (USA), Australia and New Zealand (Oceania), and Southern China and South-
east Asia (SC/SEA).
Until 2011, Victoria-lineage viruses experienced selective sweeps across all segments simul-
taneously in different regions of the world (Fig 7). However, after 2011 regional differences
became apparent, with only viruses in the USA and Europe maintaining this genome segment
linkage (Fig 7A and 7B) whilst acquisition of the Victoria-lineage NA by Yamagata-lineage
viruses in Oceania resulted in NA disassociating from the rest of the Victoria-lineage genome
(Figs 7D and 8D, S10 Fig). Regional phylogenies also highlight the persistence of a Victoria-
lineage NA gene (B/Malaysia/2506/2004 clade) that circulated almost exclusively within SC/
SEA since 2003 (Fig 8C, S10 Fig). Throughout this period, viruses from this lineage were spo-
radically observed in other regions (Fig 8A, 8B and 8D), but did not persist outside of SC/SEA.
Victoria-lineage viruses in SC/SEA show greater levels of inter- and intra-lineage reassort-
ment, maintaining genetic diversity in NA, M1, and HA (Fig 7C). Unlike Victoria-lineage
viruses, no major regional differences in the dynamics of genomic diversity were observed for
the Yamagata-lineage (Fig 7E, 7F, 7G and 7H). Rather, the accumulation of diversity was asso-
ciated with the split of the Yamagata-lineage into clades 2 and 3, with PB1 and PA showing
greater accumulation of genetic diversity over time than other genes. Although influenza B
virus sampling was more limited, these patterns of Victoria-lineage and Yamagata-lineage
virus diversity were also observed for the geographic regions of Africa and the Eastern Medi-
terranean (S12 and S13 Figs).
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Fig 6. Structural mapping of major Yamagata-lineage ‘clade-defining’ trunk substitutions on influenza B virus polymerase complex. (A)
Crystal structure of influenza B virus polymerase (PDB: 5MSG) bound to template vRNA shown in cartoon view colored by subunit, highlighting
locations of residues of interest as spheres colored by presence of change in Yamagata-lineage clade 2 (orange) or clade 3 (red) viruses. Zoomed-in
view of substitutions (B, C) at PB1-PA interface fixed in clade 2 viruses and (D, E) at PB1-vRNA interface fixed in clade 3 viruses.
https://doi.org/10.1371/journal.ppat.1006749.g006
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Whole genome analysis of Victoria-lineage B/Malaysia/2506/2004 clade viruses revealed
that they maintained a distinct genomic constellation until 2008–2009, when they underwent
extensive reassortment of all segments except the NA gene (Fig 3, S3 Fig). The first reassort-
ment event involved replacement of the HA, PB2, PB1, PA, and NP genes (95% HPD: March
2008-May 2009) with those from a globally co-circulating Victoria-lineage clade, the B/
Odessa/3886/2010 1B clade. Following this, a subset of clade 3 viruses of the Yamagata-lineage
that circulated in multiple geographic regions acquired the Victoria-lineage B/Malaysia/2506/
2004 clade NA (95% HPD: June 2011-March 2012) (Fig 2). In a separate reassortment event,
Fig 7. Genetic diversity of gene segments over time in different geographic regions. Time series of mean pairwise diversity (i.e. estimated average
branch length distance between points in phylogeny at half- year intervals, measured in years) of Victoria- and Yamagata-lineage gene segments, for
viruses collected from (A, E) USA, (B, F) Europe, (C, G) Southern China and Southeast Asia, and (D, H) Oceania.
https://doi.org/10.1371/journal.ppat.1006749.g007
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Fig 8. Time-resolved NA gene phylogenies of influenza B viruses isolated in four global regions from 2001–2014.
Maximum-clade credibility (MCC) trees are shown for Victoria- (blue) and Yamagata-lineages (red) circulating in (A,
E) USA, (B, F) Europe, (C, G) Southern China and Southeast Asia, and (D, H) Oceania. Clades are highlighted in
colored blocks, Victoria-lineage: B/Brisbane/60/2008 clade (clade 1A; BR08) in blue, B/Malaysia/2506/2004 (MA04) in
light green, B/Cambodia/30/2011 (CA11) in purple and B/Dakar/10/2012 (DA12) in dark green. For clarity, B/Odessa/
3886/2010 clade (clade 1B) is shown as part of clade 1A (BR08). Yamagata-lineage: B/Massachusetts/2/2012 (clade 2;
MA12) in orange and B/Wisconsin/1/2010 (clade 3; WI10) in light red.
https://doi.org/10.1371/journal.ppat.1006749.g008
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other viruses of the same Yamagata-lineage clade acquired the NA of the Victoria-lineage B/
Brisbane/60/2008 1A clade, indicating a propensity for this Yamagata-lineage clade to replace
its NA gene. However, despite this extensive reassortment, viruses containing the B/Malaysia/
2506/2004-like NA gene are rarely detected outside of SC/SEA. Conversely, a B/Dakar/10/
2012-like NA clade reassortant was observed in many regions of the world, but not in SC/SEA.
As influenza A viruses are known to exhibit different dynamics of lineage turnover among
regions of the world [32], we decided to compare lineage turnover of influenza B viruses circu-
lating in different geographic regions. To evaluate lineage turnover, we estimated the average
time to most recent common ancestor (TMRCA) of contemporaneous viruses at yearly time
intervals across the time-scaled phylogenies, which provides a measure of the maximum co-
circulating genetic diversity in each year. For Victoria-lineage viruses from 2002–2015, the
average estimated TMRCA is comparable in temperate regions with 4.1 years (3.6–4.7 years)
in the USA, 4.1 years (3.7–4.8 years) in Europe, and 3.9 years (3.4–4.4 years) in Oceania. In
comparison, the equivalent value for A(H3N2) in the USA and Oceania is approximately 1–2
years [32], indicating that Victoria-lineage viruses have slower lineage turnover than A(H3N2)
viruses. In contrast to the Northern and Southern temperate regions, the genetic diversity of
Victoria-lineage viruses in SC/SEA is more constant, with multiple co-circulating clades in
this region (Fig 8C, S10C and S11C Figs). These SC/SEA clades of Victoria-lineage are longer-
lasting, with an average TMRCA of 5.1 years (4.7–5.7 years). In contrast, the average TMRCA
estimates for Yamagata-lineage viruses are similar at 6.5 (5.9–7.1) in the USA, 7.2 (6.5–7.8)
years in Europe, 6.3 (5.7–6.9) in SC/SEA, and 6.7 (6.1–7.3) years in Oceania, highlighting that
a similar level of diversity of Yamagata-lineage viruses exists throughout the world due to the
co-existence of the two extant Yamagata-lineage clades.
Discussion
Here we report the global full-genome molecular epidemiology, antigenic evolution, and
phylodynamics of influenza B viruses, putting this important human pathogen into a similar
context as in analysis of influenza A viruses. Results were obtained from viruses collected
between 1987–2015, including the complete genomes of 2,651 unique viruses. Full virus
genome analysis show that in contrast to influenza B Victoria-lineage viruses that undergo
reassortment between clades, Yamagata-lineage viruses form two persisting co-circulating
clades that genetically diverge across the whole virus genome. Yamagata-lineage clade 2 and
clade 3 virus populations have a prolonged absence of intra-Yamagata-lineage reassortment,
resulting in the long-term maintenance of separate genome constellations. Moreover, esti-
mated timings of this split reveal that the divergence of Yamagata-lineage viruses began
much earlier than previously suggested by analysis of HA and NA phylogenies alone. Evolu-
tionary divergence into two distinct genetic clades began with PB1 over twenty years ago, fol-
lowed by PA and then the remaining genes. Similar observations were made regarding the
maintenance of distinct Yamagata- and Victoria-lineages in PB2, PB1, and HA genes, poten-
tially driven by “reassortment incompatibility” [17,33]. This idea has been tested and sup-
ported recently by in vitro studies [23]. However, unlike the separation between Yamagata-
and Victoria-lineage viruses, which is currently restricted to a PB2-PB1-HA complex, the
differentiation between the clades of the Yamagata-lineage is maintained across all genes.
Interestingly, we observed greater Yamagata/Victoria inter-lineage reassortment for NA and
NP than Yamagata intra-lineage reassortment. However, as there are fewer whole-genome
sequences than individual HA and NA genes, it is possible that reassortment events between
Yamagata-lineage clades remain undetected at low frequencies or in poorly sampled regions
of the world.
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The co-divergence of the Yamagata-lineage genes relates to experimental studies that sug-
gest that coevolution of PB1 with other influenza genes is important for virus fitness for influ-
enza A viruses [34,35]. Specifically, evidence suggests that optimal PB1-PA interaction is
important for efficient polymerase activity and is essential for in vitro influenza A virus viabil-
ity [34]. This is underpinned by an influenza A polymerase model proposing that initial bind-
ing between PB1 and PA is necessary for efficient transport to the nucleus and subsequent
interaction with PB2 to assemble the polymerase complex [36,37]. PB1 has also been associated
with co-selection of virus-matched HA and NA glycoproteins, with reduced virus growth
and antigen yield being observed when miss-matched in vitro [33,35,38]. Here we observe
mutations fixed on the Yamagata-lineage PB1 and PA phylogeny trunk branches at two amino
acids (PB1-I357V and PA-I617V) in contact areas of PB1 and PA for Yamagata-lineage clade 2
viruses, one of which was previously functionally characterized [29], and two amino acids
(PB1-K652R and PB1-H38Y) associated with PB1/vRNA interaction for Yamagata-lineage
clade 3 viruses. The functional significance of these requires testing; however, these data sug-
gest that adaptation of influenza B virus fitness through polymerase activity can occur by at
least two mechanisms.
Work here also highlights the importance of model selection for antigenic drift analyses
and supports the view that Victoria and Yamagata lineages have comparable rates of antigenic
drift [20] in contrast to differences in estimated Influenza B virus antigenic drift rates from
previous reports [18]. Detecting selection in influenza viruses is challenging when using tradi-
tional statistical tests based on dN/dS ratios, as such ratios are sensitive to recurrent selection
at individual sites [39]. Further, adaptations that arise from egg [40,41] and cell-culture [42,43]
passaging often appear as recurring mutations, also confounding analyses, whereas analyzing
the phylogenetic distribution of mutations can assist in the detection of positive selection.
Characterizing amino acid substitutions that occur along the trunk of Yamagata- and Victo-
ria-lineage gene phylogenies, identifies changes that become fixed in the virus population
across seasons [44,45], and are thus less likely to be passage artefacts. Notably, we did not
detect trunk substitutions at HA residues 196/197 or 198/199, which are known to be highly
variable and associated with adaptation to propagation in eggs [40,41].
The HA gene (and encoded glycoprotein) has been the focus of much influenza research,
owing to its role in immune escape. A recent study on the global circulation patterns of influ-
enza HA genes noted the persistence of influenza B virus clades, particularly Victoria-lineage
clades, which circulated exclusively in China and India for longer periods of time before
migrating to other regions [19]. Our whole-genome analysis indicates that geographical con-
straint extends to other genes of Victoria-lineage viruses, notably with greater levels of genetic
diversity for NA, M1, and NS1 detected in SC/SEA compared to other geographic regions. It
remains unclear how the spatial structure of Victoria-lineage diversity is maintained or why
Yamagata-lineage viruses do not also show this spatial pattern. Based on the incomplete avail-
ability of influenza B virus genome sequences, particularly from the Indian subcontinent, the
existence of other Yamagata- or Victoria-lineage clades may have gone undetected in our anal-
ysis. Further, we cannot exclude the possibility that seemingly geographically-constrained
virus populations have gone undetected in other regions, for example in Europe outside of our
sampling window. Nevertheless, high levels of intra- and inter-lineage reassortment in the Vic-
toria-lineage are seen and considerably affect genetic diversity, with multiple distinct geno-
types generated through reassortment events. In particular, introductions of the SC/SEA
Victoria-lineage NA into other geographic regions was associated with reassortant viruses con-
taining the Yamagata-lineage HA and genes (Fig 2). As Yamagata-lineage viruses have been
associated with a slightly older age of infection [10,13,18] and associated with more frequent
air travel [19], this may contribute to the global migration of these reassortant viruses.
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Analysis of Victoria- and Yamagata-lineage viruses shows differences in modes of anti-
genic evolution. Structural mapping of amino acid changes in HA confirmed the genetic
drift estimates, as the accumulation of adaptations in antigenically-relevant sites in each
lineage was comparable. The majority of phylogeny trunk substitutions in influenza B HA
appear in the globular head and do not map to the stalk region of HA. Whereas Victoria-
lineage viruses experience antigenic drift and turnover of antigenically-distinct viruses, the
genetic and antigenic bifurcation of Yamagata-lineage viruses has enabled these viruses to
alternate between two antigenic types over time. This provides a mechanism for generating
antigenic novelty, as previously proposed [46]. This model is supported by the amino acid
reconstruction analysis here, as two substitutions at residues located near the RBS (sites 150
and 202) accumulated along the trunk of Yamagata-lineage clade 3, but not in clade 2, poten-
tially affecting antigenicity.
The emergence and co-existence of two major antigenic Yamagata-lineage clades in a
region has implications for the epidemiological dynamics of influenza B viruses. For example,
Yamagata-lineage viruses dominated influenza B viruses in Malaysia in 2013 after a Victoria-
lineage dominated season in 2012–2013. However, in 2014 the Yamagata-lineage continued to
dominate in the influenza B virus population, through a shift from clade 2 to clade 3 viruses
[13]. This shift in patterns of dominance supports the idea that essentially three ‘lineages’ of
influenza B virus co-circulated, with distinct genotypes and antigenicity. Consequently, the
persistence of two antigenically-distinct Yamagata-lineage clades may complicate vaccine
virus selection. In contrast, we found that Victoria-lineage clade 1a and clade 1b not only
genetically reassort, but also occupy the same antigenic dimensions in antigenic map-space,
suggesting the WHO-proposed distinction of contemporary Victoria-lineage viruses may not
be antigenically relevant. The future coupling of influenza B virus whole genome sequencing
and antigenic mapping may well help in global vaccine selection and development of new
immunization strategies. The additional whole-genome sequencing data and measurements
of antigenic properties of HA presented here, particularly from under-sampled geographic
regions, contributes to ongoing public health surveillance of influenza viruses. Our findings
provide a better understanding of the interplay of epidemiological, immune-driven, and
molecular factors driving the evolution and spread of influenza B viruses worldwide.
Materials and methods
Ethics statement
Samples (specimens, clinical samples, or virus isolates) were received by the WHO Collaborat-
ing Centre (WHO CC) in London (The Crick Institute, formerly the MRC National Institute
for Medical Research) from WHO National Influenza Centers (NICs) and taken with
informed consent obtained in each country as laboratories within the WHO Global Influenza
Surveillance and Response System (GISRS) for the purposes of global surveillance of influenza
under the WHO Global Influenza Program. Samples were anonymized prior to sharing with
the WHO CC for influenza B genomic RNA extraction and Institutional Review Board review
was not applicable.
Sample collection
Samples were collected between 2007 and 2013 from 55 countries across Europe, Africa, the
Middle East, Asia, and South America. Samples for extraction were chosen based on lack of
recovery of virus (clinical specimens) and unusual profiles emerging from HI assays with a
panel of post-infection ferret antisera, along with a representative number of viruses showing
‘normal’ HI profiles.
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RT-PCR amplification and sequencing
Amplification was performed using the SuperScriptIII One-Step RT-PCR system with Plati-
num Taq DNA High Fidelity polymerase (Invitrogen) in two reactions. Each reaction con-
tained 25μl Reaction Mix (2x), 17μl DNase/RNase-free water, 1μl of each primer (10μM), 1μl
SuperScriptIII RT/Platinum Taq High Fidelity and 5μl of the template RNA. Primers used for
the HA, NP, NA, MP, and NS genes were: FluB-S1-F (5’ GCC GGA GCT CTG CAG ATA
TCA GCA GAA GCA 3’) and FluB-S1-R (GCC GGA GCT CTG CAG ATA TCA GTA GWA
RYA A 3’). Primers used for the polymerase complex genes (PB2, PB1, PA) were: FluB(555)-
L1-F (5’ CTG AGT CCG AAC ATT GAG AGC AGA AGC G 3’) and FluB(555)-L1-R (5’ CTG
AGT CCG AAC ATT GAG AGT AGA AAC AC 3’) [47]. The cycling conditions were 42˚C
for 15 min, 55˚C for 15 min, 60˚C for 5 min, 96˚C for 2 min, and then 5 cycles (94˚C for 30 s,
45˚C for 30 s, slow ramp (0.5˚C /sec from 45˚C to 66˚C) and 68˚C for 3 min), followed
by 35 cycles (96˚C for 30 s, 66˚C for 30 s, and 68˚C for 3 min) and finally 68˚C for 5 min
with subsequent examination of amplicons by agarose gel electrophoresis. Amplicons were
pooled and sequenced on Illumina MiSeq or HiSeq 2000 platforms using the paired-end
150bp technology. The resultant reads were quality-controlled using QUASR version 7.01 [48]
to remove primer sequences, trim low-quality bases from the 3’-ends of reads until the median
Phred-scaled quality was 35 and filter reads shorter than 145bp. All raw sequencing reads are
available in the European Nucleotide Archive (ENA) under study accessions PRJEB19198 and
PRJEB2261.
Genome assembly
Genomes were generated using de novo assembly and reference-based mapping methods. In
brief, quality-controlled reads were de novo assembled using the SPAdes genome assembler
version 2.4.0 [49] with kmer size 127 and minimum contiguous sequence (contig) size of 300.
Resulting contigs were arranged by genomic segment and filtered to retain those covering at
least 70% of the open reading frame for each segment. In the case where multiple contigs were
assembled for a segment, a custom Python script was used to estimate the relative abundance
of each contig in the reads (i.e. to determine composition of variants) and retain the majority
variant. For reference-based mapping, unique references were selected for each sample by per-
forming a BLAST search on a subset of the reads and retaining the best match for each seg-
ment. Reads were mapped against the reference sequences using SMALT version 0.5.0 [50],
and consensus sequences generated using SAMtools version 0.1.8 [51] and QUASR version
7.01 [48]. Sequences generated in this study are available in GISAID under accession numbers
listed in S3 Table.
Sequence collation and alignment
All available influenza B virus gene segment sequences, excluding artificial recombinant and
laboratory-generated variants, were downloaded from the NCBI Influenza Virus Resource
(IVR) [52] and GISAID (http://gisaid.org) repositories on 28 August 2015. Acknowledgement
of the sources of the GISAID sequences is given in S4 Table and accession numbers of Gen-
Bank sequences are listed in S5 Table. After duplicate samples and sequences containing less
than 70% of the segment coding sequence were removed, the downloaded sequences were
combined with the 413 genome sequences generated for this study (representing 382 unique
viruses), resulting in a dataset containing 2651 unique, complete genome sequences, (from
2992 PB1, 3090 PB2, 3012 PA, 9167 HA, 3178 NP, 6608 NA, 3403 MP, and 5159 NS sequences)
sampled worldwide between 1987 and 2015. Separate alignments were constructed for the lon-
gest coding region of each segment (PB2, PB1, PA, HA, NP, NA, M1, NS1) in AliView version
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1.17.1 [53]. To reduce sampling bias from over-represented regions in the time-resolved phy-
logenetic reconstructions, we downsampled epidemiologically-linked isolates while maintain-
ing phylogenetic structure, temporal range and spatial distribution.
Phylogenetic analysis
Maximum likelihood (ML) phylogenies for each segment were estimated using RAxML ver-
sion 7.8.6 [54] under a general-time reversible (GTR) nucleotide substitution model with
gamma-distributed rates to represent among-site heterogeneity. Clade confidence was esti-
mated by bootstrapping with 1,000 pseudo-replicates. Trees were visualized, rooted to the old-
est virus and colour-coded by lineage and clade using FigTree version 1.4.2 (http://tree.bio.ed.
ac.uk/software/figtree/). The resulting phylogenetic trees were inspected by linear regression
and residual analysis using TempEst v1.4 [55] to identify incorrectly dated or anomalous
sequences, which were subsequently removed from the alignments.
Molecular clock-dating and evolutionary analysis
Molecular clock phylogenies were inferred for each gene segment using the Markov chain
Monte Carlo (MCMC) method implemented in BEAST version 1.8.0 [56]. Separate Victoria-
and Yamagata-lineage phylogenies were inferred for the PB2, PB1, and HA genes. For all runs,
the SRD06 nucleotide substitution model [57] was used, along with a strict molecular clock, as
suggested by the linear regression analysis, and a Bayesian Skyride coalescent prior [58]. At
least two MCMC chains were run for 200 million states, and combined with a 10% burn-in
and sampling every 40,000 states. Mean pairwise diversity measures and 95% highest posterior
densities across 9,000 trees were inferred for viruses from each major geographic region in
yearly time intervals using PACT (http://bedford.io/projects/PACT/). Amino acid substitu-
tions along the HA phylogenies were inferred using ‘renaissance’ counting ancestral recon-
struction methods [59,60]. The ‘trunk’ branches of each phylogenetic tree were defined by
tracing from the most recent contemporaneous samples back to the oldest. Nonsynonymous
substitutions along the trunk lineage were calculated in year time intervals to determine the
mean nonsynonymous substitutions/year count and 95% highest posterior densities across a
posterior set of 1000 trees.
Genotype assignment
Viruses were categorized into major Yamagata- and Victoria-clades, as previously reported
in WHO influenza centre reports for HA and NA genes (https://www.crick.ac.uk/research/
worldwide-influenza-centre/annual-and-interim-reports), from the ML and time-resolved
phylogenies where viruses grouped together in well-supported clades (bootstrap value >60%
and/or posterior probability >0.6). Each gene was assigned to one of the defined clades to gen-
erate a complete genotype for each sample. Phylogenetics trees were annotated with resulting
genotypes and visualized in R using the ggtree package [61]. Data analysis and visualization
scripts are available in Github repository https://github.com/pclangat/global-fluB-genomes.
Antigenic data and integrated cartography
We compiled HI measurements and HA sequence data, which were previously published [20]
or collected by the WHO Collaborating Centre (WHO CC) in London. Known egg-adapted
viruses were removed, resulting in a final HI dataset of 309 Victoria- and 308 Yamagata-line-
age viruses isolated from 1988 to 2013. We implemented a Bayesian multidimensional scaling
(BMDS) cartographic model to jointly infer antigenic and phylogenetic relationships of the
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viruses as previously described [20,62]. Briefly, MCMC was used to sample virus and serum
locations in two antigenic dimensions, as well as virus avidities, serum potencies, MDS preci-
sion, and virus and serum location precisions, using an empirical tree distribution of 1,000
posterior trees inferred for HA sequences separately (as detailed above). Two antigenic dimen-
sions were specified based on previous findings that two-dimensional models provide the best
predictive power for antigenic mapping of influenza B virus [20]. MCMC chains were run for
500 million states with sampling every 200,000 states with a 10% burn-in, and checked for con-
vergence in Tracer v1.6 (http://tree.bio.ed.ac.uk/software/tracer/). We obtained a total of 2,000
trees from which the maximum clade credibility tree was summarized in TreeAnnotator
v1.8.2. We estimated the rate of antigenic drift for each lineage, by calculating the mean
Euclidean distance in antigenic units (AU) of all antigenic map locations at yearly time inter-
vals from the inferred phylogenetic root. From this time series of Euclidean distances, we esti-
mated the rates of antigenic drift (in AU/year) using linear regression. 95% highest posterior
density (HPD) estimates were used to measure the statistical uncertainty in these drift rate
inferences from the posterior sample of trees. Source data, including BEAST input XML files,
HI tables, and output trees are available in Dryad repository https://doi:10.5061/dryad.s1d37
[64].
Structural mapping
Amino acid substitutions occurring along the trunk of each lineage were visualized on the
crystal structures of the HA trimers for viruses of the Yamagata-lineage B/Yamanashi/166/98
(PDB ID: 4M40, [63]) and Victoria-lineage B/Brisbane/60/2008 (PDB ID: 4FQM, [27]), and
influenza B virus PB2-PB1-PA polymerase complex bound to viral RNA (PDB ID: 5MSG,
[30]) using PyMOL Molecular Graphics System, Version 1.7.6.0, Schro¨dinger, LLC. Structural
features were mapped as described in S8 Fig.
Supporting information
S1 Fig. Maximum-clade credibility trees for all major influenza B virus genes. Branches of
phylogenies are labeled with amino acid substitutions occurring along the phylogenetic ‘trunk’
and are colored by well-supported clade distinctions. Nodes with greater than 0.70 posterior
probability support are shown with circle node shapes.
(PDF)
S2 Fig. MCC tree inferred from 522 Yamagata-lineage PB1 gene sequences and corre-
sponding genotype constellations. See Fig 2 legend for details.
(PDF)
S3 Fig. MCC tree inferred from 902 Victoria-lineage NA gene sequences and correspond-
ing genotype constellations. See Fig 2 legend for details.
(PDF)
S4 Fig. Antigenic and genetic evolutionary relationships of influenza B viruses inferred
using a BMDS model with fixed serum potencies and virus avidities. See Fig 4 legend for
further details.
(PDF)
S5 Fig. Antigenic map configurations for 309 Victoria-lineage and 308 Yamagata-lineage
viruses inferred under BMDS models with co-estimated (A, B) and fixed (C,D) serum
potencies and virus avidities, shown in two antigenic dimensions and one time dimension.
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See Fig 4 legend for further details and S1 and S2 Videos for animated visualizations.
(PDF)
S6 Fig. Estimated global relative frequencies for Yamagata-lineage clade 2 and clade 3
viruses. As reported on nextflu.org (accessed 8 August 2016).
(PDF)
S7 Fig. Structural mapping of phylogenetic ‘trunk’ amino acid substitutions on Victoria-
lineage and Yamagata-lineage HA trimers. HA1 units are in darker grey while HA2 are
white-grey, with the RBS shown in pink. (A) Victoria-lineage virus B/Brisbane/60/2008
(PDB: 4FQM), (B) Yamagata-lineage virus B/ Yamanashi/166/98 (PDB: 4M40) and (C) rotated
Yamagata-lineage virus B/Yamanashi/166/98. On the front- facing selected HA1 monomer
(darkest grey), trunk mutations are labeled with residue number and coloured by location: in
antigenic epitope (orange) or other (blue), while they are shown in black on the other two
monomers for simplicity.
(PDF)
S8 Fig. Structure-based sequence alignment of influenza B/Yamagata and B/Victoria HA1.
Alignment was performed with Multalin (Corpet 1988) and plotted with ESPRIPT (Gouet
et al. 1999). Secondary structure elements were assigned using the crystal structure of hemag-
glutinin influenza virus B/ Yamanashi/166/1998 in complex with avian-like receptor LSTa
(PDB accession number 4M44) (Ni et al. 2013). Secondary structure elements are shown with
an arrow and helices are shown as spirals. Residues which are highlighted red are fully con-
served, residues which are colored red are partially conserved, and residues which are black
are not conserved. Residues which are solvent accessible (as determined by ESPRIPT) are
highlighted by black (fully exposed) and gray (partially exposed) bars below the sequence. Resi-
dues located at the receptor binding site were determined using the PISA EBI server (Krissinel
and Henrick 2007) and are annotated with pink bars below the sequence. An asterisk is placed
at positions at sites which do not map on or nearby the major epitopes. Four previously
described (Wang et al. 2008) major epitopes on the Influenza B virus are annotated below the
sequence with orange bars. Residues in close- proximity to these regions which undergo fre-
quent amino-acid substitutions in influenza B virus HA (Ni et al. 2013; Wang et al. 2008;
Nunes et al. 2008; Pechirra et al. 2005; Shen et al. 2009) are annotated with green bars.
(PDF)
S9 Fig. Structural mapping of additional Yamagata-lineage ‘clade-defining’ trunk substitu-
tions on influenza B polymerase complex. Substitutions not located at potential PB1/PA or
PB1/vRNA interface regions are highlighted as spheres coloured by emergence in Yamagata-
lineage clade 2 (orange) or clade 3 (red) viruses. See Fig 6 legend for details.
(PDF)
S10 Fig. Time-resolved HA gene phylogenies of influenza B viruses isolated in four major
global regions from 2001–2014. Clades are highlighted in colored blocks: Yamagata-lineage
B/Florida/4/2006 (FR06) clade shown in yellow. See Fig 8 legend for other details.
(PDF)
S11 Fig. Relative genetic diversity of HA genes of influenza B viruses circulating in different
regions of the world. Effective population sizes over time inferred by Bayesian skyride analysis
for HA of Victoria- (blue) and Yamagata-lineage (red) viruses isolated in (A) the USA, (B)
Europe, (C) SC/SEA and (D) Oceania. Solid lines represent median values and shaded areas
represent 95% highest probability densities (HPD) credible intervals across MCMC samples.
(PDF)
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S12 Fig. Genetic diversity of gene segments over time in less-sampled geographic regions.
Time series of mean pairwise diversity for viruses collected from countries of the African
Region of WHO (AFRO) and Eastern Mediterranean Region of WHO (EMRO) as listed on
http://www.who.int/influenza/gisrs_laboratory/national_influenza_centres/list/en/ (Accessed
8 August 2016). Due to limited sampling, these regions are not discussed in the main manu-
script. See Fig 6 legend for further details.
(PDF)
S13 Fig. Time-resolved HA and NA gene phylogenies of influenza B viruses isolated in
WHO AFRO and EMRO regions from 2001–2014. Due to limited sampling, these regions
are not discussed in the main text. See Fig 5 legend for further details.
(PDF)
S1 Table. Inferred trunk mutations and dates of emergence for influenza B virus gene phy-
logenies.
(XLS)
S2 Table. Structural features and nature of select amino acid substitutions inferred along
trunk lineages of Victoria and Yamagata HA phylogenies.
(XLS)
S3 Table. GISAID accessions and meta data for sequences generated in this study.
(XLS)
S4 Table. GISAID acknowledgement table for sequences used in this study.
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S5 Table. NCBI accessions and meta data for sequences used in this study.
(XLS)
S1 Video. Animated rotating view of three-dimensional antigenic map visualization for
Victoria-lineage viruses shown in S5A Fig.
(MP4)
S2 Video. Animated rotating view of three-dimensional antigenic map visualization for
Yamagata-lineage viruses shown in S5B Fig.
(MP4)
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